...Oxford Immunotec develops diagnostics using its T-SPOT technology, which quantifies antigen-specific T cells. The company's T-SPOT.TB...
...pathogen that can cause symptoms resembling Lyme disease. Oxford Immunotec Global plc (NASDAQ:OXFD), Abingdon, U.K. Mary Romeo T-SPOT.TB Oxford...

...Oxford Immunotec develops diagnostics using its T-SPOT technology, which quantifies antigen-specific T cells. The company's T-SPOT.TB...
...screen donated blood for Babesia, a tick-borne pathogen that can cause symptoms resembling Lyme disease. Mary Romeo OMS721 T-SPOT.TB Omeros...

...of shares at $13-$15. The $12 price values the company at $196.4 million. Oxford Immunotec's T-Spot.TB...

...Immunotec is developing tests using its T-SPOT technology, which quantifies antigen-specific T cells. The company's T-Spot.TB...

...Immunotec is developing tests using its T-SPOT technology, which quantifies antigen-specific T cells. The company's T-Spot.TB...

...Immunotec is developing tests using its T-SPOT technology, which quantifies antigen-specific T cells. The company's T-Spot.TB...

...Oxford Immunotec said Japan's Ministry of Health, Labor and Welfare (MHLW) approved the T-SPOT.TB test as...
...ELISpot) assay at a rate of $106.12 (see BioCentury, Jan. 23). Oxford Immunotec, which markets T-SPOT.TB...
...the highest TB rates in the developed world." Oxford Immunotec Ltd. , Abingdon, U.K. Product: T-SPOT.TB...

...Immunotec Ltd. (Abingdon, U.K.) said Japan's Ministry of Health, Labor and Welfare (MHLW) approved the T-SPOT.TB...
...reimburses the enzyme-linked immunospot (ELISpot) assay at a rate of $106.12. Oxford Immunotec, which markets T-SPOT.TB...

...Kaiser Permanente Ventures; Spark Ventures; and the University of Oxford participated. Oxford Immunotec markets the T-SPOT.TB...

...Immunotec said the Center for Medicare and Medicaid Services (CMS) increased the reimbursement for its T-SPOT.TB...
...as an aid for diagnosing Mycobacterium tuberculosis infection. Oxford Immunotec Ltd. , Abingdon, U.K. Product: T-SPOT.TB...